Granules India Limited (BOM:532482)
India · Delayed Price · Currency is INR 863.35
+8.95 (1.05%)
At close: Jul 7, 2026
Granules India Market Cap
Granules India has a market cap or net worth of 213.94 billion as of July 7, 2026. Its market cap has increased by 70.99% in one year.
Market Cap
213.94B
Enterprise Value
219.57B
Revenue
53.66B
Ranking
n/a
PE Ratio
35.30
Stock Price
863.35
Market Cap Chart
Since February 7, 2003, Granules India's market cap has increased from 163.70M to 213.94B, an increase of 130,587.45%. That is a compound annual growth rate of 35.84%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 7, 2026 | 213.94B | 47.29% |
| Dec 31, 2025 | 145.25B | 1.29% |
| Dec 31, 2024 | 143.40B | 45.94% |
| Dec 29, 2023 | 98.26B | 27.40% |
| Dec 30, 2022 | 77.13B | -7.49% |
| Dec 31, 2021 | 83.37B | -4.42% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Abbott India | 549.30B |
| GlaxoSmithKline Pharmaceuticals | 405.35B |
| J. B. Chemicals & Pharmaceuticals | 379.44B |
| Rubicon Research | 215.33B |
| AstraZeneca Pharma India | 207.45B |
| Caplin Point Laboratories | 192.72B |
| Jubilant Pharmova | 153.45B |
| Viyash Scientific | 128.41B |